Treatment of estrogen-receptor positive breast cancer and estrogen- receptor negative breast cancer with retinoid with CH.sub.2 OH at the side chain terminal position

摘要

Certain retinoids with CH.sub.2 OH at the side chain terminal position, preferably 4-oxoretinol, inhibit growth of estrogen-receptor positive and estrogen-receptor negative breast cancer tumor cell lines and have utility for adjuvant therapy and treatment of metastatic disease.